---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-003052"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2024-02-05T23:59:59+00:00"
generated_at: "2026-06-06T09:30:38.570914+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mesa Labs Q3 revenue down 1.5%; operating loss of $67K; core organic revenue declines 9%

## Summary
- Revenue $53.5M, down 1.5% YoY; core organic revenue declined 9%.
- Operating loss of $67K vs income $3.2M prior year; net income $2.1M up 369% on unusual items.
- Non-GAAP adjusted operating income excl. unusual items $12.0M, down 6.8% YoY but up 7.3% sequentially.
- Clinical Genomics down 19% on China anti-corruption; Biopharm capital constrained but consumables +16.5%.
- Calibration Solutions revenue +12.9%, gross margin +600 bps; GKE acquisition added $3.8M revenue.

## SEC filing metadata
- accession: 0001437749-24-003052
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2024-02-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000143774924003052/0001437749-24-003052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000143774924003052/mlab20240202_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-003052
- JSON: https://secwatch.observer/filing/0001437749-24-003052.json
- Plain text: https://secwatch.observer/filing/0001437749-24-003052.txt

## Key facts
- Earnings Releases
  MESA LABORATORIES INC /CO/ reported third fiscal quarter ended December 31, 2023 results: revenue $53,473, net income $2,116, EPS $0.39 per diluted share of common stock.
  - Period: third fiscal quarter ended December 31, 2023
  - Revenue: $53,473
  - Net income: $2,116
  - EPS: $0.39 per diluted share of common stock
  - Result: reported results
  source text: ● Non-GAAP adjusted operating income excluding unusual items as a percentage of revenues increased sequentially to 22.4% Executive Commentary (amounts in thousands) “Revenues of $53,473 for the quarter decreased 1.5% as compared to the third quarter of fiscal year 2023 (“3Q23”), due primarily to a 9.0% core organic revenues (“core organic”) decrease which was
  evidence_url: https://www.sec.gov/Archives/edgar/data/724004/000143774924003052/0001437749-24-003052-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.